Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/BMS-906024> ?p ?o }
Showing triples 1 to 52 of
52
with 100 triples per page.
- BMS-906024 abstract "New Phase I drug structure by Bristol-Myers Squibb disclosed at the spring 2013 American Chemical Society meeting in New Orleans to treat breast, lung, and colon cancers and leukemia. The drug works as an pan-Notch inhibitor. The structure is one of a set patented in 2012, and it currently being studied in clinical trials.".
- BMS-906024 iupacName "(2R,3S)-N-[(3S)-1-Methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl]-2,3-bis(3,3,3-trifluoropropyl)succinamide".
- BMS-906024 pubchem "66550890".
- BMS-906024 thumbnail BMS-906024.svg?width=300.
- BMS-906024 wikiPageID "39087520".
- BMS-906024 wikiPageLength "2927".
- BMS-906024 wikiPageOutDegree "6".
- BMS-906024 wikiPageRevisionID "702407497".
- BMS-906024 wikiPageWikiLink American_Chemical_Society.
- BMS-906024 wikiPageWikiLink Bristol-Myers_Squibb.
- BMS-906024 wikiPageWikiLink Category:Benzodiazepines.
- BMS-906024 wikiPageWikiLink Category:Experimental_cancer_treatments.
- BMS-906024 wikiPageWikiLink Notch_signaling_pathway.
- BMS-906024 wikiPageWikiLink Phases_of_clinical_research.
- BMS-906024 wikiPageWikiLinkText "BMS-906024".
- BMS-906024 c "26".
- BMS-906024 chemspiderid "28536138".
- BMS-906024 f "6".
- BMS-906024 h "26".
- BMS-906024 inchi "1".
- BMS-906024 inchikey "AYOUDDAETNMCBW-GSHUGGBRBK".
- BMS-906024 iupacName "-N-[-1-Methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl]-2,3-bissuccinamide".
- BMS-906024 molecularWeight "556.5".
- BMS-906024 n "4".
- BMS-906024 o "3".
- BMS-906024 pubchem "66550890".
- BMS-906024 pubchemsubstance "152143555".
- BMS-906024 smiles "CN1c2ccccc2Cc3ccccc3".
- BMS-906024 stdinchi "1".
- BMS-906024 stdinchikey "AYOUDDAETNMCBW-GSHUGGBRSA-N".
- BMS-906024 wikiPageUsesTemplate Template:Antineoplastic-drug-stub.
- BMS-906024 wikiPageUsesTemplate Template:Drugbox.
- BMS-906024 wikiPageUsesTemplate Template:Notability.
- BMS-906024 wikiPageUsesTemplate Template:Reflist.
- BMS-906024 subject Category:Benzodiazepines.
- BMS-906024 subject Category:Experimental_cancer_treatments.
- BMS-906024 type ChemicalSubstance.
- BMS-906024 type Drug.
- BMS-906024 type Chemical.
- BMS-906024 type ChemicalObject.
- BMS-906024 type Thing.
- BMS-906024 type Q8386.
- BMS-906024 comment "New Phase I drug structure by Bristol-Myers Squibb disclosed at the spring 2013 American Chemical Society meeting in New Orleans to treat breast, lung, and colon cancers and leukemia. The drug works as an pan-Notch inhibitor. The structure is one of a set patented in 2012, and it currently being studied in clinical trials.".
- BMS-906024 label "BMS-906024".
- BMS-906024 sameAs Q15408421.
- BMS-906024 sameAs m.0swnhpw.
- BMS-906024 sameAs BMS-906024.
- BMS-906024 sameAs BMS-906024.
- BMS-906024 sameAs Q15408421.
- BMS-906024 wasDerivedFrom BMS-906024?oldid=702407497.
- BMS-906024 depiction BMS-906024.svg.
- BMS-906024 isPrimaryTopicOf BMS-906024.